Cora

Cora Therapeutics is a Toronto-based life sciences company dedicated to developing advanced antioxidant formulations that protect cellular and mitochondrial DNA from oxidative stress and ionizing radiation. The company's flagship product, DNA Halo, is a clinically proven, patented nutraceutical complex designed to mitigate the risk of DNA breaks and associated long-term health conditions, such as cancer and cardiovascular disease, caused by medical imaging (CT/X-ray) and cosmic radiation. Led by interventional neuroradiologist Dr. Kieran Murphy, the company targets high-risk populations including medical professionals, frequent fliers, and military personnel. Cora Therapeutics continues to expand its research into broader applications, including the prevention of carcinogen-induced DNA damage.